TipRanks
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
Want to see VRTX full AI Analyst Report?

Compare Vertex Pharmaceuticals (VRTX) vs. Competitors

6,801 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
$547.29
$128.84B
29.35
31.32%
21 Buy
4 Hold
1 Sell
Strong Buy
Alnylam Pharma
$240.08
$32.06B
39.27
-47.02%
19 Buy
3 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$12.38B
168.26
15.96%
16 Buy
5 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$18.92
$2.12B
-13.97
8.59%
4 Buy
8 Hold
4 Sell
Hold
Intellia Therapeutics
$13.51
$1.70B
-3.61
-24.64%
6 Buy
4 Hold
2 Sell
Moderate Buy
Crispr Therapeutics AG
$60.90
$5.47B
-11.88
-10.14%
8 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VRTX
Vertex Pharmaceuticals
508.34
125.21
32.68%
ALNY
Alnylam Pharma
239.56
-219.36
-47.80%
BMRN
BioMarin Pharmaceutical
63.94
10.00
18.54%
SRPT
Sarepta Therapeutics
20.11
1.46
7.83%
NTLA
Intellia Therapeutics
12.14
-5.12
-29.66%
CRSP
Crispr Therapeutics AG
56.56
-5.54
-8.92%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts